Phase II trial of bevacizumab (Avastin) plus pemetrexed (Alimta) and carboplatin in previously untreated advanced non-small cell lung cancer (NSCLC)
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 20 Jan 2006 New trial record.